Insider Trading Activity Agios Pharmaceuticals Inc (NASDAQ:AGIO) – CEO Sold 49,374 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Agios Pharmaceuticals Inc (NASDAQ:AGIO)

David P Schenkein , CEO of Agios Pharmaceuticals Inc (NASDAQ:AGIO) reportedly Sold 49,374 shares of the company’s stock at an average price of 90.4 for a total transaction amount of $4,463,409.60 SEC Form

Insider Trading History For Agios Pharmaceuticals Inc (NASDAQ:AGIO)

On 7/29/2013 Celgene European Investment Co, Major Shareholder, bought 708,333 with an average share price of $18.00 per share and the total transaction amounting to $12,749,994.00.

On 1/21/2014 Glenn Goddard, SVP, sold 10,000 with an average share price of $34.71 per share and the total transaction amounting to $347,100.00.

On 1/27/2014 Glenn Goddard, SVP, sold 7,000 with an average share price of $26.29 per share and the total transaction amounting to $184,030.00.

On 2/10/2014 Glenn Goddard, SVP, sold 6,000 with an average share price of $30.44 per share and the total transaction amounting to $182,640.00.

On 3/3/2014 Scott Biller, Insider, sold 6,000 with an average share price of $29.85 per share and the total transaction amounting to $179,100.00.

On 3/3/2014 John Duncan Higgons, COO, sold 8,000 with an average share price of $29.85 per share and the total transaction amounting to $238,800.00.

On 3/7/2014 John Duncan Higgons, COO, sold 14,646 with an average share price of $41.41 per share and the total transaction amounting to $606,490.86.

Analyst Ratings History For Agios Pharmaceuticals Inc (NASDAQ:AGIO)

On 8/10/2016 Goldman Sachs Group Reiterated Rating Neutral with a price target of $46.00
On 8/19/2016 BTIG Research Initiated Coverage of rating Neutral
On 1/17/2017 CIBC Upgraded rating Market Perform ➝ Outperform
On 2/16/2017 Cowen Reiterated Rating Buy
On 8/1/2017 Janney Montgomery Scott Reiterated Rating Hold
On 8/2/2017 Leerink Swann Upgraded rating Market Perform ➝ Outperform with a price target of $50.00 ➝ $80.00
On 12/12/2017 Canaccord Genuity Set Price Target of rating Buy with a price target of $90.00

Recent Trading Activity for Agios Pharmaceuticals Inc (NASDAQ:AGIO)
Shares of Agios Pharmaceuticals Inc closed the previous trading session at 89.36 up +0.74 0.84% with 88.25 shares trading hands.